Magnolia Neurosciences is Drug Discovery in United States that focus on neuronal injuries business. Founded in 2018. They cover business area such as Provider, novel therapeutic, neurodegeneration, neuronal injury, medical professional, patient, condition, neuronal cell death.
2018
( 8 years old in 2026 )
Neuronal Injuries
-
2815 Eastlake Avenue East
Suite 300
Seattle, WA 98102
United States
Private
Providernovel therapeuticneurodegenerationneuronal injurymedical professionalpatientconditionneuronal cell death
* We use standard office opening hours in near Magnolia Neurosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Magnolia Neurosciences is Drug Discovery business from United States that founded in 2018 (8 years old in 2026), Magnolia Neurosciences business is focusing on Neuronal Injuries.
Magnolia Neurosciences headquarter office and corporate office address is located in 2815 Eastlake Avenue East Suite 300 Seattle, WA 98102 United States.
Magnolia Neurosciences was founded in United States.
In 2026, Magnolia Neurosciences is currently focus on neuronal injuries sector.
Above is snippet of Google Trends for "neuronal injuries" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Magnolia Neurosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
